![The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/1d0546dc-c3e6-4911-98cd-f06f2aec1f70/gr1.gif)
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial - The Lancet
![Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trust - Petrina Douglas-Hall, Olubanke Dzahini, Fiona Gaughran, Ahmed Bile, David Taylor, 2017 Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trust - Petrina Douglas-Hall, Olubanke Dzahini, Fiona Gaughran, Ahmed Bile, David Taylor, 2017](https://journals.sagepub.com/cms/10.1177/2045125316672573/asset/images/large/10.1177_2045125316672573-fig2.jpeg)
Variation in dose and plasma level of lamotrigine in patients discharged from a mental health trust - Petrina Douglas-Hall, Olubanke Dzahini, Fiona Gaughran, Ahmed Bile, David Taylor, 2017
![Efficacy and tolerability of lamotrigine in Juvenile Myoclonic Epilepsy in adults: A prospective, unblinded randomized controlled trial - ScienceDirect Efficacy and tolerability of lamotrigine in Juvenile Myoclonic Epilepsy in adults: A prospective, unblinded randomized controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1059131113001994-gr1.jpg)
Efficacy and tolerability of lamotrigine in Juvenile Myoclonic Epilepsy in adults: A prospective, unblinded randomized controlled trial - ScienceDirect
![Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial - The Lancet Neurology Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2001017965/2003846843/gr1.jpg)